Further, metformin has been found to reduce the risk of cancer in diabetic patients and combination treatment of metformin with small molecule STAT3 inhibitors has been proposed as a method of improving therapeutic efficacy in breast cancer[36]. This evidence concerns the gene STAT3 and breast carcinoma.